Search Results - Mark L Stevens

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Rickettsia typhi infection presenting as severe ARDS by Liem T. Tran, Jessica L. Helms, Miguel Sierra-Hoffman, Mark L. Stevens, Rafael Deliz-Aguirre, Mirams T. Castro-Lainez, Rafael J. Deliz

    Published in IDCases (2019-01-01)
    Get full text
    Article


  2. 2

    Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital. by Kimberly Saddler, Jason Zhang, Jennifer Sul, Pruthvi Patel, Miriams Castro-Lainez, Mark L Stevens, Sheryl Kosler, Emily Lowery, Miguel Sierra-Hoffman

    Published in PLoS ONE (2021-01-01)
    Get full text
    Article


  3. 3

    Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies by Fernando Valerio-Pascua, Fernando Baires, Anupamjeet Kaur Sekhon, Mari L. Tesch, Estela Jackeline Pineda, Syed A. A. Rizvi, Jarmanjeet Singh, David Abraham Cortes-Bandy, Amy C. Madril, Jana Radwanski, Anita S. Lewis, Miguel Sierra-Hoffman, Mark L. Stevens, Franck F. Rahaghi

    Published in BMC Infectious Diseases (2024-11-01)
    Get full text
    Article


  4. 4

    Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study by Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires, Luis G. Benitez, Cesar Burgos, Anupamjeet Kaur Sekhon, Nicole Crisp, Anita S. Lewis, Jana Radwanski, Marco Bermudez, Karen Sanchez Barjun, Oscar Diaz, Elsa Palou, Rossany E. Escalante, Carlos Isai Hernandez, Mark L. Stevens, Deke Eberhard, Manuel Sierra, Tito Alvarado, Omar Videa, Miguel Sierra-Hoffman, Fernando Valerio-Pascua

    Published in Frontiers in Pharmacology (2022-11-01)
    Get full text
    Article


Search Tools: